Validity of Pulmonary Tuberculosis Control Success Index (TBCSI) Instrument


M. Choiroel Anwar
Irwan Budiono
Alfiana Ainun Nisa


The target for reducing the incidence of TB in 2019 was 245/100,000 population. However, the national TB incidence is at 321/100,000 population, implying that mapping the performance of PHC is inevitable to help accelerate control efforts. This study aims to develop an instrument, the “TB control success index” (TBCSI), and measure the TBCSI achievement of all PHC in Semarang City. Quantitative research was conducted to construct the TBCSI instrument, and a validated TBCSI instrument was used to measure the TBCSI of all PHC individuals in Semarang City. The validity test showed Aiken’s V coefficient for each TBCSI instrument question item > 0.92. Furthermore, the TBCSI results at the Semarang City showed an average of 0.9332. The average index of the 6 TBCSI dimensions were 0.8959 (program leadership dimension); 0.8495 (TB service access dimension); 0.9667 (risk factor control dimension); 0.9797 (increase in partnership dimension); 0.9240 (increasing community independence dimension); and 0.9874 (management strengthening dimension). The TBCSI instrument was proven valid to measure the success rate of PHC in implementing TB control programs. Therefore, the TBCSI of all PHCs in Semarang City was included in the good category.


Author Biographies

M. Choiroel Anwar, Poltekes Kemenkes RI Semarang, Indonesia

Scopus ID: 57213161974

Irwan Budiono, Universitas Negeri Semarang, Indonesia

Scopus ID: 57194195131

Alfiana Ainun Nisa, Universitas Negeri Semarang, Indonesia

Scholar Google

How to Cite
Anwar, M. C., Budiono, I., & Nisa, A. A. (2022). Validity of Pulmonary Tuberculosis Control Success Index (TBCSI) Instrument. Unnes Journal of Public Health, 11(1), 82-89.


Budiono, I. 2013. Pengembangan Model Indeks Pembangunan Gizi. KESMAS - Jurnal Kesehatan Masyarakat, 8 (2): 166–175.
Chadha, V.K. & Praseeja, P. 2019. Active Tuberculosis Case Finding in India – the Way Forward. Indian Journal of Tuberculosis, 66 (1): 170–177.
Choi, S. & Jung, E. 2014. Optimal Tuberculosis Prevention and Control Strategy from a Mathematical Model based on Real Data. Bulletin of Mathematical Biology, 76 (7): 1566–1589.
Deitchman, S. 2013. Enhancing Crisis Leadership in Public Health Emergencies. Disaster Medicine and Public Health Preparedness, 7 (5): 534–540.
Feng et al. 2019. Risk Factors of Multidrug-Resistant Tuberculosis in China: a Meta-Analysis. Public Health Nursing, 36 (3): 257–269.
Go et al. 2018. Tuberculosis Prevention and Care in Korea: Evolution of Policy and Practice. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 11: 28–36.
Huynh et al. 2015. Tuberculosis Control Strategies to Reach the 2035 Global Targets in China: the Role of Changing Demographics and Reactivation Disease. BMC Medicine, 13 (88): 1–17.
Jeffries et al. 2017. Role of the Health Department in Tuberculosis Prevention and Control—Legal and Public Health Considerations. Mycrobiology Spectrum, 5 (2): 261–282.
Kemenkes. 2019. Hasil Utama Riset Kesehatan Dasar 2018. Jakarta: Kementerian Kesehatan RI.
Kemenkes RI. 2011. Pedoman Nasional Pengendalian Tuberkulosis-Keputusan Menteri Kesehatan Republik Indonesia Nomor 364. Jakarta: Kementerian Kesehatan RI.
Kemenkes RI. 2017. Kebijakan Program Penanggulangan Tuberkulosis Indonesia, Direktorat Jenderal Pencegahan dan Pengendalian Penyakit Kemenkes RI. Jakarta: Kementerian Kesehatan RI.
Koh, H. 2009. Leadership in Public Health. Journal of Cancer Education, 24: 11–18.
Lines, G., Hunter, P. & Bleything, S. 2015. Improving Treatment Completion Rates for Latent Tuberculosis Infection: a Review of Two Treatment Regimens at a Community Health Center. Journal of Health Care for the Poor and Underserved, 26 (4): 1428–1439.
López et al. 2020. Is Tuberculosis Elimination a Feasible Goal in Colombia by 2050?. Health Policy and Planning, 35 (1): 47–57.
Nishimura et al. 2018. Risk of Tuberculosis Infection among Health Care Workers and Nursing Students in Japan. Journal of Infection and Chemotherapy, 24 (11): 921–924.
Orcau, A., Caylà, J.A. & Martínez, J.A. 2011. Present Epidemiology of Tuberculosis (Prevention and Control Programs. Enfermedades Infecciosas y Microbiologia Clinica, 29 (1): 2–7.
Patil, T.S. & Deshpande, A.S. 2018. Innovative Strategies in the Diagnosis and Treatment of Tuberculosis: a Patent Review (2014–2017). Expert Opinion on Therapeutic Patents, 28 (8): 615–623.
Saini, V. & Garg, K. 2020. Case Finding Strategies under National Tuberculosis Elimination Programme (NTEP). Indian Journal of Tuberculosis, 67 (4): S101–S106.
Schito et al. 2015. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Clinical Infectious Diseases, 61 (3): S102–S118.
Wang, L., Liu, J. & Chin, D.P. 2007. Progress in Tuberculosis Control and the Evolving Public-Health System in China. The Lancet, 369 (9562): 691–696.
Whang, S., Choi, S. & Jung, E. 2011. A Dynamic Model for Tuberculosis Transmission and Optimal Treatment Strategies in South Korea. Journal of Theoretical Biology, 279 (1): 120–131.
World Health Organization. 2018. Global Tuberculosis Report 2018. World Health Organization.